Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-13

  Pericolini, Eva ^a   Gabrielli, Elena ^a   Bistoni, Giovanni ^b   Cenci, Elio ^a   Perito, Stefano ^a   Chow, Siu Kei ^c   Riuzzi, Francesca ^a   Donato, Rosario ^a   Casadevall, Arturo ^c   Vecchiarelli, Anna ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; GALACTAN; GALACTOXYLOMANNAN; GLYCORECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG; BACTERIAL POLYSACCHARIDE; POLYSACCHARIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL PROLIFERATION; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; TUMOR CELL LINE;

MURINAE;

ANIMALS; ANTIGENS, CD45; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION; LYMPHOCYTE ACTIVATION; MICE; POLYSACCHARIDES; POLYSACCHARIDES, BACTERIAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77958588490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012720     Document Type: Article

References (56)

1. Thomas ML (1989) The leukocyte common antigen family. Annu Rev Immunol 7: 339-369.
2. Irie-Sasaki J, Sasaki T, Penninger JM (2003) CD45 regulated signaling pathways. Curr Top Med Chem 3: 783-796.
3. Trowbridge IS, Thomas ML (1994) CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 12: 85-116.
4. Wang HY, Xu X, Ding JH, Bermingham JR, Jr., Fu XD (2001) SC35 plays a role in T cell development and alternative splicing of CD45. Mol Cell 7: 331-342.
5. Wallace VA, Fung-Leung WP, Timms E, Gray D, Kishihara K, et al. (1992) CD45RA and CD45RBhigh expression induced by thymic selection events. J Exp Med 176: 1657-1663.
6. Uittenbogaart CH, Higashitani S, Schmid I, Vollger LW, Boone T, et al. (1990) Interleukin-4 induces expression of the CD45RA antigen on human thymocyte subpopulations. Int Immunol 2: 1179-1187.
7. Bell EB, Sparshott SM (1990) Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 348: 163-166.
8. Dang AM, Phillips JA, Lin T, Raveche ES (1996) Altered CD45 expression in malignant B-1 cells. Cell Immunol 169: 196-207.
9. Lim TS, Murphy JW (1980) Transfer of immunity to cryptococcosis by Tenriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect Immun 30: 5-11.
10. Vaishnav VV, Bacon BE, O'Neill M, Cherniak R (1998) Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res 306: 315-330.
11. Zaragoza O, Rodrigues ML, De Jesus M, Frases S, Dadachova E, et al. (2009) The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol 68: 133-216.
12. De Jesus M, Chow SK, Cordero RJ, Frases S. Casadevall A Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. Eukaryot Cell.
13. Chaka W, Verheul AF, Vaishnav VV, Cherniak R, Scharringa J, et al. (1997) Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun 65: 272-278.
14. Villena SN, Pinheiro RO, Pinheiro CS, Nunes MP, Takiya CM, et al. (2008) Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Cell Microbiol 10: 1274-1285.
15. De Jesus M, Nicola AM, Frases S, Lee IR, Mieses S, et al. (2009) Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage. J Immunol 183: 3885-3894.
16. Pericolini E, Cenci E, Monari C, De Jesus M, Bistoni F, et al. (2006) Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cell Microbiol 8: 267-275.
17. Pericolini E, Gabrielli E, Cenci E, De Jesus M, Bistoni F, et al. (2009) Involvement of glycoreceptors in galactoxylomannan-induced T cell death. J Immunol 182: 6003-6010.
18. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, et al. (2001) CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 Oglycans. J Immunol 167: 5697-5707.
19. James PG, Cherniak R (1992) Galactoxylomannans of Cryptococcus neoformans. Infect Immun 60: 1084-1088.
20. de Belder AN, Wik KO (1975) Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr Res 44: 251-257.
21. Hyman R, Stallings V (1974) Complementation patterns of Thy-1 variants and evidence that antigen loss variants ''pre-exist'' in the parental population. J Natl Cancer Inst 52: 429-436.
22. Wegener AM, Letourneur F, Hoeveler A, Brocker T, Luton F, et al. (1992) The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 68: 83-95.
23. Chou YK, Culbertson N, Rich C, LaTocha D, Buenafe AC, et al. (2004) T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice. J Neurosci Res 77: 670-680.
24. Brezak MC, Quaranta M, Mondesert O, Galcera MO, Lavergne O, et al. (2004) A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res 64: 3320-3325.
25. Contour-Galcera MO, Lavergne O, Brezak MC, Ducommun B, Prevost G (2004) Synthesis of small molecule CDC25 phosphatases inhibitors. Bioorg Med Chem Lett 14: 5809-5812.
26. Haas A, Weckbecker G, Welzenbach K (2008) Intracellular Phospho-Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot. Cytometry A 73: 799-807.
27. Kunte DP, Wali RK, Koetsier JL, Hart J, Kostjukova MN, et al. (2005) Downregulation of the tumor suppressor gene C-terminal Src kinase: an early event during premalignant colonic epithelial hyperproliferation. FEBS Lett 579: 3497-3502.
28. Migliorati G, Nicoletti I, Pagliacci MC, D'Adamio L, Riccardi C (1993) Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81: 1352-1358.
29. Mustelin T, Tasken K (2003) Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J 371: 15-27.
30. McNeill L, Salmond RJ, Cooper JC, Carret CK, Cassady-Cain RL, et al. (2007) The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses. Immunity 27: 425-437.
31. Hermiston ML, Xu Z, Weiss A (2003) CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21: 107-137.
32. Hermiston ML, Zikherman J, Zhu JW (2009) CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol Rev 228: 288-311.
33. Amin S, Parker A, Mann J (2008) ZAP70 in chronic lymphocytic leukaemia. Int J Biochem Cell Biol 40: 1654-1658.
34. Liu FT (2000) Galectins: a new family of regulators of inflammation. Clin Immunol 97: 79-88.
35. Hernandez JD, Baum LG (2002) Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 12: 127R-136R.
36. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, et al. (2002) Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23: 313-320.
37. Hsu DK, Liu FT (2004) Regulation of cellular homeostasis by galectins. Glycoconj J 19: 507-515.
38. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, et al. (2003) CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 63: 8302-8311.
39. Perillo NL, Pace KE, Seilhamer JJ, Baum LG (1995) Apoptosis of T cells mediated by galectin-1. Nature 378: 736-739.
40. Majeti R, Xu Z, Parslow TG, Olson JL, Daikh DI, et al. (2000) An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103: 1059-1070.
41. Earl LA, Baum LG (2008) CD45 glycosylation controls T-cell life and death. Immunol Cell Biol 86: 608-615.
42. Arimura Y, Ogimoto M, Mitomo K, Katagiri T, Yamamoto K, et al. (2001) CD45 is required for CD40-induced inhibition of DNA synthesis and regulation of c-Jun NH2-terminal kinase and p38 in BAL-17 B cells. J Biol Chem 276: 8550-8556.
43. Xu Z, Weiss A (2002) Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immunol 3: 764-771.
44. Dupere-Minier G, Desharnais P, Bernier J. Involvement of tyrosine phosphatase CD45 in apoptosis. Apoptosis 15: 1-13.
45. Steff AM, Fortin M, Philippoussis F, Lesage S, Arguin C, et al. (2003) A cell death pathway induced by antibody-mediated cross-linking of CD45 on lymphocytes. Crit Rev Immunol 23: 421-440.
46. Pajusto M, Ihalainen N, Pelkonen J, Tarkkanen J, Mattila PS (2004) Human in vivo-activated CD45R0(+) CD4(+) T cells are susceptible to spontaneous apoptosis that can be inhibited by the chemokine CXCL12 and IL-2, -6, -7, and -15. Eur J Immunol 34: 2771-2780.
47. Schraven B, Peter ME (1995) APO-1(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett 368: 491-494.
48. Latinis KM, Koretzky GA (1996) Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87: 871-875.
49. Koretzky GA, Picus J, Schultz T, Weiss A (1991) Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci U S A 88: 2037-2041.
50. D'Oro U, Sakaguchi K, Appella E, Ashwell JD (1996) Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol Cell Biol 16: 4996-5003.
51. Wang Y, Johnson P (2005) Expression of CD45 lacking the catalytic protein tyrosine phosphatase domain modulates Lck phosphorylation and T cell activation. J Biol Chem 280: 14318-14324.
52. Hur YG, Yun Y, Won J (2004) Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction. J Immunol 172: 79-87.
53. Sharif-Askari E, Gaucher D, Halwani R, Ma J, Jao K, et al. (2007) p56Lck tyrosine kinase enhances the assembly of death-inducing signaling complex during Fas-mediated apoptosis. J Biol Chem 282: 36048-36056.
54. Wang X, Martindale JL, Holbrook NJ (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435-39443.
55. Bickers DR, Athar M (2006) Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 126: 2565-2575.
56. Kirchberger S, Majdic O, Bluml S, Schrauf C, Leitner J, et al. (2008) The cytoplasmic tail of CD45 is released from activated phagocytes and can act as an inhibitory messenger for T cells. Blood 112: 1240-1248.